Advances in nanomedicine for the treatment of infectious diseases caused by viruses

Viruses have a worldwide impact on healthcare and social and economic growth because they are the largest cause of mortality due to infectious diseases. Furthermore, the long-term conventional drug use comes with substantial risks to public health, such as the rapid evolution of drug resistance and...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials science Vol. 11; no. 1; pp. 3431 - 3449
Main Authors Dash, Somya Ranjan, Kundu, Chanakya Nath
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 16.05.2023
Subjects
Biocompatibility
Communicable Diseases
COVID-19
Drug delivery systems
Drug Delivery Systems - methods
Economic development
Health services
Human papillomavirus
Humans
Impact analysis
Infectious diseases
Nanomaterials
Nanomedicine - methods
Public health
SARS-CoV-2
Side effects
Viral diseases
Virus Diseases - drug therapy
Online AccessGet full text

Cover

More Information
Summary:Viruses have a worldwide impact on healthcare and social and economic growth because they are the largest cause of mortality due to infectious diseases. Furthermore, the long-term conventional drug use comes with substantial risks to public health, such as the rapid evolution of drug resistance and the emergence of secondary side effects. Therefore, it is necessary to develop new methods for the treatment of virus-related diseases. In this case, the use of nanomaterial-based nanomedicines possesses tremendous advantages over the traditional treatment approach. Nanomaterial-based drug delivery systems have unique features that make them promising candidates in the pursuit of therapeutic benefits. In this review, we present the various biocompatible nanomaterials that show promise as nanomedicines for anti-viral therapy. Also, we include how current developments in nanomedicine are being used to treat and prevent the most common viral illnesses such as the flu, HIV, SARS-CoV-2, monkeypox, and human papillomaviruses. An efficient anti-viral therapy strategy based on nanomedicine.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:2047-4830
2047-4849
DOI:10.1039/d2bm02066a